scispace - formally typeset
Journal ArticleDOI

DNA released from dying host cells mediates aluminum adjuvant activity

Reads0
Chats0
TLDR
The finding that host DNA released from dying cells acts as a damage-associated molecular pattern that mediates alum adjuvant activity may increase the understanding of the mechanisms of action of current vaccines and help in the design of new adjuvants.
Abstract
Aluminum-based adjuvants (aluminum salts or alum) are widely used in human vaccination, although their mechanisms of action are poorly understood. Here we report that, in mice, alum causes cell death and the subsequent release of host cell DNA, which acts as a potent endogenous immunostimulatory signal mediating alum adjuvant activity. Furthermore, we propose that host DNA signaling differentially regulates IgE and IgG1 production after alum-adjuvanted immunization. We suggest that, on the one hand, host DNA induces primary B cell responses, including IgG1 production, through interferon response factor 3 (Irf3)-independent mechanisms. On the other hand, we suggest that host DNA also stimulates 'canonical' T helper type 2 (T H 2) responses, associated with IgE isotype switching and peripheral effector responses, through Irf3-dependent mechanisms. The finding that host DNA released from dying cells acts as a damage-associated molecular pattern that mediates alum adjuvant activity may increase our understanding of the mechanisms of action of current vaccines and help in the design of new adjuvants.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Multi-faceted regulation of IgE production and humoral memory formation.

TL;DR: Recent advances in understanding of the mechanisms that control the production of IgE and formation of Ig E-type humoral memory are summarized, focusing on the B cell immune responses.
Journal ArticleDOI

Pharmacodynamic and safety considerations for influenza vaccine and adjuvant design.

TL;DR: This review aims to explain the recently developed genomics analysis-based vaccine adjuvant safety evaluation tools verified by AddaVaxTM and polyinosinic-polycytidylic acid (poly I:C) using 18 biomarker genes and whole-virion inactivated influenza vaccine as a toxicity control.
Journal ArticleDOI

Clinical phase II and III studies of an AS03-adjuvanted H5N1 influenza vaccine produced in an EB66® cell culture platform.

TL;DR: An AS03‐adjuvanted H5N1 influenza vaccine produced in an EB66® cell culture platform (KD‐295) is developed and presented at the European Vaccine Conference in Strasbourg.
References
More filters
Journal ArticleDOI

Pattern Recognition Receptors and Inflammation

TL;DR: The role of PRRs, their signaling pathways, and how they control inflammatory responses are discussed.
Journal ArticleDOI

A Toll-like receptor recognizes bacterial DNA.

TL;DR: It is shown that cellular response to CpG DNA is mediated by a Toll-like receptor, TLR9, and vertebrate immune systems appear to have evolved a specific Toll- like receptor that distinguishes bacterial DNA from self-DNA.
Journal ArticleDOI

Cryopyrin activates the inflammasome in response to toxins and ATP

TL;DR: It is shown that cryopyrin-deficient macrophages cannot activate caspase-1 in response to Toll-like receptor agonists plus ATP, the latter activating the P2X7 receptor to decrease intracellular K+ levels.
Journal ArticleDOI

Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization

TL;DR: It is demonstrated that silica and aluminum salt crystals activated inflammasomes formed by the cytoplasmic receptor NALP3, which senses lysosomal damage as an endogenous 'danger' signal.
Journal ArticleDOI

Sterile inflammation: sensing and reacting to damage

TL;DR: The triggers and receptor pathways that result in sterile inflammation and its impact on human health are reviewed.
Related Papers (5)